IP Library › Granted Patent US 10,086,045
Granted Patent B2
US 10,086,045 · App. 15/254,526 · Granted Oct 2, 2018

Methods of treatment using stem cell mobilizers

Inventor: Andrew MacGregor Cameron (Baltimore, MD)
Assignee: The Johns Hopkins University
A61K38/193A61K31/395A61K31/4427
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,086,045
App. No.
15/254,526
Granted
Oct 2, 2018
Kind
B2
Abstract

The present invention relates to the field of stem cells. In one aspect, the present invention provides methods of treating a subject with acute liver injury comprising administering to the subject a therapeutically effective amount of at least one stem cell mobilizer. In particular embodiments, the subject is treated with plerixafor and granulocyte colony-stimulating factor (G-CSF).

Claims (12)

1. A method for treating a subject with acute liver injury comprising administering to the subject a therapeutically effective amount of plerixafor and granulocyte colony stimulating factor (G-CSF) to mobilize CD34+ stem cells from the bone marrow into the peripheral blood.

2. The method of claim 1 , wherein plerixafor is administered in a range of about 200 μg to about 3 mg per kg of body weight.

3. The method of claim 2 , wherein plerixafor is administered in a dose of about 2 mg/kg of body weight.

4. The method of claim 1 , wherein G-CSF is administered in a range of about 10 μg to about 1 mg/kg of body weight.

5. The method of claim 4 , wherein G-CSF is administered in a dose of about 300 μg/kg of body weight.

6. The method of claim 1 , wherein the acute liver injury comprises acute liver failure.

7. The method of claim 1 , wherein the acute liver injury comprises post-surgical resection.

8. A method for treating a subject with acute liver failure comprising administering to the subject a therapeutically effective amount of plerixafor and granulocyte colony stimulating factor (G-CSF) to mobilize CD34+ stem cells from the bone marrow into the peripheral blood.

9. The method of claim 8 , wherein plerixafor is administered in a range of about 200 μg to about 3 mg per kg of body weight.

10. The method of claim 9 , wherein plerixafor is administered in a dose of about 2 mg/kg of body weight.

11. The method of claim 8 , wherein G-CSF is administered in a range of about 10 μg to about 1 mg/kg of body weight.

12. The method of claim 11 , wherein G-CSF is administered in a dose of about 300 μg/kg of body weight.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 22, 2018
From: CAMERON, ANDREW MACGREGOR
To: THE JOHNS HOPKINS UNIVERSITY
Reel/Frame 046416/0130 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 18, 2018
From: CAMERON, ANDREW MACGREGOR
To: THE JOHNS HOPKINS UNIVERSITY
Reel/Frame 046377/0610 →
Continuity (3)
Continuation 13636733
Provisional Application 61316481 · Mar 23, 2010
Related Publication 20170340709A1 · Nov 30, 2017
Cited By (1)
US 12,653,860